Despite years of investigation, breast cancer remains a major cause of death worldwide. Phage display
is a powerful molecular method in which peptide and protein libraries can be displayed via genetic fusions on the
surface of phages. This approach has tremendous potential for biomedical applications and has already facilitated
the discovery of specific antibodies, specific antigens, and peptides with potential roles in the diagnosis and
treatment of malignancies including breast cancer. In this review, we discuss the new and the latest advancements
in the applications of the phage display technique in the provision of immune therapeutics for breast cancer.
Use of a Phage Display Technique to Identify Potential Osteoblast Binding Sites Within Osteoclast Lacunae